Literature DB >> 16051379

Intrahippocampal nicotine and neurosteroids effects on the anxiety-like behaviour in voluntary and chronic alcohol-drinking rats.

Elena Martín-García1, Marc Pallarès.   

Abstract

Considerable evidence suggests that the anxiolytic effects of ethanol may be one of the factors that promotes alcohol consumption. The present study aimed to characterize the effects of intrahippocampal administrations of nicotine and the two neurosteroids pregnenolone sulphate (PregS) and allopregnanolone (AlloP) on anxiety-like behaviours in alcohol-drinking rats. A long-lasting free-choice drinking procedure with an early availability (from weaning) of an alcoholic solution (10% (v/v) ethanol, 3% (w/v) glucose in distilled water) was used. After 80 days of consumption, alcohol-drinking and control rats were deprived of food and assigned at random to six groups. After 100 days of consumption, each group received two consecutive intrahippocampal (dorsal CA1) injections. First injection: nicotine (4.6 microg, 20 mM) or saline; second injection: PregS (5 ng, 24 microM), AlloP (0.2 microg, 1.26 microM) or saline. Following the injections, novelty-directed activity (open field, OF), and motor coordination (80 degrees inclined screen) were tested. Blood alcohol concentrations (BACs) were assessed. Anxiolytic-like effects of voluntary ethanol consumption and intrahippocampal AlloP administration were observed. Alcohol intake increased the novelty-induced ambulation and exploration of central areas, and decreased defecation. The high exploration levels induced by AlloP decreased significantly over sessions, indicating a rapid habituation to the environmental conditions. Motor coordination was deteriorated by ethanol consumption. These results demonstrate the effects of chronic alcohol intake and neurosteroid administration on anxiety-related behaviours, and suggest an important role of the hippocampal GABA(A) receptor in these behaviours.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051379     DOI: 10.1016/j.bbr.2005.06.007

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

1.  Progesterone turnover to its 5α-reduced metabolites in the ventral tegmental area of the midbrain is essential for initiating social and affective behavior and progesterone metabolism in female rats.

Authors:  C A Frye; J J Paris
Journal:  J Endocrinol Invest       Date:  2010-11-08       Impact factor: 4.256

2.  A post-training intrahippocampal anxiogenic dose of the neurosteroid pregnenolone sulfate impairs passive avoidance retention.

Authors:  E Martín-García; M Pallarés
Journal:  Exp Brain Res       Date:  2008-07-30       Impact factor: 1.972

3.  Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits.

Authors:  Rebecca K Sripada; Christine E Marx; Anthony P King; Jessica C Rampton; S Shaun Ho; Israel Liberzon
Journal:  Biol Psychiatry       Date:  2013-01-21       Impact factor: 13.382

4.  Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice.

Authors:  Ethan H Beckley; Andrea M Fretwell; Michelle A Tanchuck; Katherine R Gililland; John C Crabbe; Deborah A Finn
Journal:  Neuropharmacology       Date:  2007-10-22       Impact factor: 5.250

5.  Effects and Mechanisms of 3α,5α,-THP on Emotion, Motivation, and Reward Functions Involving Pregnane Xenobiotic Receptor.

Authors:  Cheryl A Frye; J J Paris; A A Walf; J C Rusconi
Journal:  Front Neurosci       Date:  2012-01-19       Impact factor: 4.677

6.  GABA A /Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-Like Behaviour in Female Rats.

Authors:  Juan Francisco Rodríguez-Landa; Fabiola Hernández-López; Lucía Martínez-Mota; Damiana Scuteri; Blandina Bernal-Morales; Eduardo Rivadeneyra-Domínguez
Journal:  Front Behav Neurosci       Date:  2022-01-05       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.